Homologous Recombination Repair in Biliary Tract Cancers: A Prime Target for PARP Inhibition?

SIMPLE SUMMARY: Biliary tract cancers (BTCs) are a rare but deadly group of gastrointestinal tumors that are often diagnosed in the advanced stages of disease. Despite large studies investigating optimal systemic therapy options in BTCs, current chemotherapies provide only modest benefits in overall...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Chao, Kulasekaran, Monika, Roy, Tina, Decker, Brennan, Alexander, Sonja, Margolis, Mathew, Jha, Reena C., Kupfer, Gary M., He, Aiwu R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140037/
https://www.ncbi.nlm.nih.gov/pubmed/35626165
http://dx.doi.org/10.3390/cancers14102561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140037/
https://www.ncbi.nlm.nih.gov/pubmed/35626165
http://dx.doi.org/10.3390/cancers14102561

Ejemplares similares